Urokinase plasminogen activator and ist inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer. - Fredstorp-Lidebring,M.; Bendahl,P.O.; Brunner,N.; Casslen,B.; Hogberg,T.; Langstrom-Einarsson,E.; Willen,R.; Ferno,M. (Eur J Cancer, 2001)